Conduent (CNDT): +34% Gain in 30 Days Driven by Undervaluation Recognition
Key Takeaways
- CNDT stock rose +34% over the past 30 days, driven by recognition of its undervaluation and leadership in healthcare payer operations.
- Over the past quarter, shares gained +1%, amid volatile trading with a dip following Q4 earnings before a partial recovery.
- Strong new business annual contract value (ACV) growth and institutional ownership supported sentiment.
- Q4 results showed revenue stability but an earnings miss, contributing to early-quarter pressure.
- Positive analyst commentary highlighted trading at a deep discount to intrinsic value.
Conduent (CNDT): Company Overview and Market Position
Conduent Incorporated (CNDT) delivers digital business solutions and services across commercial, government, and transportation sectors. The company focuses on transaction-intensive processing, analytics, and automation, enabling clients to streamline operations and gain data-driven insights. From what I see, Conduent maintains a solid position in the competitive business process services industry through long-term contracts with government entities and key strengths in healthcare payer operations and transportation management. Its recurring revenue from government deals provides stability, and the recent push into AI-driven automation aligns well with industry trends, which helps account for its resilience despite stock volatility.
CNDT Stock Performance: Last 30 Days vs. Quarter
Over the last 30 days, CNDT stock climbed from approximately $1.27 to $1.70, marking a +34% gain. The uptrend was volatile, with shares rebounding sharply from mid-March lows around $1.15, backed by steady volume increases and momentum toward recent highs near $1.76.
Looking at the past quarter, shares edged up +1% from about $1.68 to $1.70. Trading stayed range-bound with elevated volatility, including a drop to $1.15 in mid-March before a recovery, as broader pressures were countered by selective buying interest.
Drivers Behind CNDT's 30-Day Rally
The +34% surge in CNDT stock over the last 30 days came from investors increasingly recognizing the company's undervaluation. One analysis pointed out the stock trading at a deep discount to its long-term intrinsic value, with a one-month return exceeding 32% as of mid-April, which fueled buying momentum. Conduent's status as a leader in Everest Group's 2026 Healthcare Payer Intelligent Operations PEAK Matrix assessment added to the positive sentiment, underscoring its capabilities in analytics and automation for payers. I also checked this using Tickeron’s AI Screener to see how the stock stacks up against industry peers.
Trading volume rose with the rally, as shares tested highs amid commentary on new business wins. Without major earnings or deals taking center stage, these elements shifted sentiment and lifted the price from oversold territory.
What Shaped CNDT's Quarterly Performance
CNDT's performance over the quarter balanced company-specific hurdles with core strengths. Q4 2025 earnings, released in February, reported a net loss of $0.09 per share—wider than the expected $0.06 loss—alongside stable revenue of around $770 million. This miss sparked a sell-off, driving shares to $1.15 lows in March amid market caution on profitability.
Positive notes from the earnings call helped offset this, including $152 million in new business ACV, up 11% year-over-year, especially in transportation and government segments. Institutional ownership at 73% offered a floor, and steady demand for government outsourcing amid fiscal spending supported stabilization. These factors combined for a modest net gain despite the volatility.
Trending AI Robots
One resource I rely on for ideas is Tickeron's Trending AI Robots page, which highlights top-performing AI trading bots from its library of hundreds of algorithms trading thousands of tickers. These bots are selected based on recent performance metrics, win rates, and market relevance, covering strategies like momentum, mean reversion, and sector-specific plays for day trades or swings. With transparent tracking of returns, drawdowns, and Sharpe ratios, it's a practical way to explore diversification or backtest concepts that fit your approach.
CNDT Stock Outlook: Key Factors to Watch
For CNDT, I'm watching upcoming Q1 2026 earnings closely, as they should clarify revenue trends and ACV growth in transportation and healthcare. Progress on AI-enhanced services and new contracts could sway sentiment. Industry trends in business process outsourcing, including government budget demands, stay important. Macro factors like interest rates impacting spending and healthcare regulatory shifts are worth tracking too. On the risk side, execution toward profitability and competition in automation remain key concerns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
CNDT's Stochastic Oscillator sits in oversold zone for 5 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNDT advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNDT as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CNDT turned negative on June 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
CNDT moved below its 50-day moving average on June 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CNDT crossed bearishly below the 50-day moving average on June 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CNDT entered a downward trend on June 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.317) is normal, around the industry mean (7.302). P/E Ratio (13.615) is within average values for comparable stocks, (67.825). CNDT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.983). CNDT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.068) is also within normal values, averaging (20.763).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of business process outsourcing services
Industry InformationTechnologyServices
Advertisement